BRIEF-Cynata Therapeutics initiates formal regulatory engagement for U.S. market
April 18, 2017 at 19:11 PM EDT
* Cynata expects to receive FDA's written advice arising from pre-ind meeting by July 2017.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|